4-Chloro-3-methylpyridine-2-carbonitrile, 98+%, 250mg

(S)-1-Benzyl-5-oxo-pyrrolidine-3-carboxylic acid methyl ester, 97.0%, 5g

5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine, 250mg

4-(1-(TRIFLUOROMETHYL)CYCLOPROPYL)ANILINE, 90.0%, 1g

Ethyl (E)-3-(2-(benzyloxy)-4-((2-methoxyethoxy)methoxy)phenyl)acrylate, 97%, 10g

(E)-3-(2-Methoxypyridin-3-yl)acrylic acid, 98%, 5g

trans-4-Propylcyclohexanol>95.0%(GC)1g

(S)-Benzyl (1-(4-amino-5-carbamoyl-1H-pyrazol-1-yl)propan-2-yl)carbamate, 95.0%, 100mg

1-(3-Bromophenyl)pyrrolidin-2-one, 95.0%, 1g

Matraces de fondo redondo Matraces de cuello triple, 500 ml, 29/32, 1 Pieza

2-(3-(Pyridin-2-yl)-1,2,4-oxadiazol-5-yl)aniline, 98%, 500mg

4-(2-phenylethyl)-5-sulfanylidene-1,2,4-triazolidin-3-one, 97%, 250mg

5-Bromo-1H-pyrrolo[2,3-b]pyridine-2,3-dione, 95.0%, 250mg